%0 Journal Article
%1 Buttel2010
%A Buttel, I C
%A Voller, K
%A Schneider, C K
%D 2010
%E Saf, Curr Drug
%J Curr Drug Saf
%K kalinke
%N 4
%P 287-292
%T Immunogenicity and its Impact on Benefit/Risk Considerations in the Authorisation of Biopharmaceuticals.
%U http://www.ncbi.nlm.nih.gov/pubmed/20615175
%V 5